News | June 24, 2011

American Heart Association CEO Praises Graphic Tobacco Warning Labels


June 24, 2011 — American Heart Association (AHA) CEO Nancy Brown praised the new, larger tobacco packaging warning labels unveiled this week by the U.S. Food and Drug Administration (FDA). The labels include graphic images of disease caused by tobacco.

“New cigarette warning labels unveiled today by the Food and Drug Administration will help give us the momentum needed to eradicate tobacco use in our nation,” Brown said. “For the first time in 25 years, cigarette warning labels have been dramatically altered to graphically demonstrate the specific, serious health risks associated with smoking, and these warnings will not only tell smokers how bad tobacco use is, but also direct them to smoking cessation resources that can help them quit.”

According to the Centers for Disease Control and Prevention, more than 45 million Americans smoke cigarettes - about 20 percent of the population - and one in five high school students still smoke. The new health warnings represent an aggressive approach to reducing smoking rates that have leveled off in recent years as tobacco companies continue to launch campaigns to entice new smokers and maintain current customers.

“The American Heart Association strongly believes that the graphic depictions of smoking-related diseases on cigarette packages will drive home the message that tobacco use is an equal opportunity killer, affecting smokers and nonsmokers alike,” Brown said. “In the U.S., about one-third of smoking-related deaths are linked to heart disease and stroke. Cigarette smoking causes about 443,000 premature deaths each year and about 49,000 of these deaths are due to second-hand smoke. Undoubtedly, the new graphic health warnings will heighten awareness about the dangers of smoking and, more importantly, encourage smokers to quit and discourage smoking initiation. We're confident that the new labels will move us closer to our goal of making the nation 100 percent smoke-free.”

For more information: www.heart.org



Related Content

News | Cardiovascular Clinical Studies

July 16, 2025 — Medtronic has announced that the first patient has been enrolled in the PEripheral Onyx Liquid Embolic ...

Home July 22, 2025
Home
News | Cardiovascular Clinical Studies

June 11, 2025 — Bayer and the Broad Institute have have extended their research collaboration of 10 years by an ...

Home June 11, 2025
Home
News | Cardiovascular Clinical Studies

May 27, 2025 — Despite scientific advances in cardiovascular care, people in living in rural areas and other communities ...

Home May 27, 2025
Home
News | Cardiovascular Clinical Studies

May 20, 2025 — Shockwave Medical, Inc., part of Johnson & Johnson MedTechhas announced the 30-day primary endpoint ...

Home May 21, 2025
Home
News | Cardiovascular Clinical Studies

Jan. 13, — A new cohort study among 103,642 adults found that current use of cigars was associated with increased risk ...

Home January 14, 2025
Home
News | Cardiovascular Clinical Studies

Nov. 22, 2024 — BridgeBio Pharma, Inc. recently announced that the U.S. Food and Drug Administration (FDA) approved ...

Home November 25, 2024
Home
News | Cardiovascular Clinical Studies

Nov. 18, 2024 — Silence Therapeutics presented end-of-treatment data from its Phase 2 ALPACAR-360 study of zerlasiran, a ...

Home November 18, 2024
Home
News | Cardiovascular Clinical Studies

Aug. 15, 2024 — According to a new study being presented at ACC Asia 2024 in Delhi, India, drinking over 400 mg of ...

Home August 14, 2024
Home
Videos | Cardiovascular Clinical Studies

As part of DAIC's continuing Thought Leadership Series, this month Editorial Director Melinda Taschetta-Millane sits ...

Home July 30, 2024
Home
News | Cardiovascular Clinical Studies

July 25, 2024 — BioCardia, Inc., a global leader in cellular and cell-derived therapeutics for the treatment of ...

Home July 25, 2024
Home
Subscribe Now